Joachim Schrader

Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention

Joachim Schrader, Stephan Lüders, Anke Kulschewski et al. · Stroke · 2005 · 763 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

The ACCESS Study

Joachim Schrader, Stephan Lüders, Anke Kulschewski et al. · Stroke · 2003 · 650 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

Kazem Rahimi, Zeinab Bidel, Milad Nazarzadeh et al. · The Lancet · 2021 · 321 citations · Full text

Pharmacy, Geriatric Medicine, Pharmacology +17

The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure – a prospective, randomized, controlled prevention trial of the German Hypertension League

Stephan Lüders, Joachim Schrader, Jürgen Berger et al. · Journal of Hypertension · 2008 · 230 citations

Medicine, Pharmacology, Pharmacotherapy +17

Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis

Emma Copland, Dexter Canoy, Milad Nazarzadeh et al. · The Lancet Oncology · 2021 · 104 citations · Full text

Public Health, Oncology, Pharmacotherapy +12